key: cord-0755154-9n3may7k authors: Chaubal, Gaurav; Hatimi, Hunaid; Nanavati, Aditya; Deshpande, Apoorv; Andankar, Parmanand; Biradar, Vishnu; Gupte, Parijat; Hanchnale, Pavan; Bhalerao, Suryabhan; Tambe, Shrinivas title: Pediatric living donor intestine transplant following an atypical complication of COVID‐19: A unique case report from India date: 2021-09-09 journal: Am J Transplant DOI: 10.1111/ajt.16798 sha: df4c3ca6f6a102cb1824f84d5a8230745654ec1a doc_id: 755154 cord_uid: 9n3may7k Coronavirus disease‐19 (COVID‐19) infection causing severe gastrointestinal complications is rare. A 9‐year‐old child after recovering from mild COVID‐19 infection developed small bowel gangrene due to superior mesenteric artery thrombosis. He required resection of entire necrotic small bowel along with caecum causing ultra‐short bowel syndrome. Reverse transcriptase‐polymerase chain reaction (RT‐PCR) done on the resected specimen was positive for COVID‐19. He was maintained on individualized parenteral nutrition for 3 months. A living donor intestinal transplant was performed using 200 cm of ileum donated by the patient's father. The graft function was satisfactory and was not complicated with thrombosis, infection, reactivation of latent COVID‐19 or rejection. He could be weaned off completely from parenteral nutrition by postoperative day 21. The donor had an uneventful recovery. Six month follow‐up was satisfactory with the child achieving complete enteral autonomy as well as target goal nutrition. Thrombotic phenomena associated with COVID‐19 infection can affect larger vessel‐like superior mesenteric artery leading to small bowel gangrene. Intestine transplant could be done safely after 3 months of recovery from COVID‐19 without any adverse outcomes. Further studies are required to establish optimal timing and safety of small bowel transplant in this situation. complication: surgical/technical, health services and outcomes research, infection and infectious agents -viral, infectious disease, intestine/multivisceral transplantation patients need extensive resection followed by either long-term total parenteral nutrition (TPN), intestinal lengthening procedures, or small intestine transplant (SIT). The latter is done in extreme cases depending on the extent of resection and in patients who develop life-threatening complication secondary to prolonged administration of TPN to offer long-term survival. COVID-19 pandemic brought the global transplant activity to a standstill. This was mainly due to diversion of life-saving resources for management of patients suffering from COVID infections. Second, there were concerns regarding the increased transmission of virus to the recipients along with safety of recipients receiving immuno-suppression during the pandemic. This case report highlights the successful management of a patient by living donor intestine transplant (LDIT) who suffered from massive small bowel gangrene and discusses the outcome of the same. A 9-year-old male child suffered with symptoms of cough and fever which lasted for 3 days. His nasopharyngeal swab for SARS-CoV-2 was positive for which he was hospitalized in a peripheral hospital. One week later, after his symptoms subsided, he felt acute onset generalized pain in his abdomen with guarding and board-like rigidity. Then he underwent emergency exploratory laparotomy in the same peripheral hospital during which he was found to have massive small bowel gangrene secondary to superior mesenteric artery thrombosis. This necessitated resection of entire small bowel starting from 10 cm distal to duodeno-jejunal flexure extending up to caecum. Proximal jejunum was brought out as an end jejunostomy, and distal end was closed and placed intraperitoneally. Stomal gangrene with retraction of stoma occured on day 6 of the index surgery, for which reexploratory laparotomy was performed at our tertiary care hospital. His height, weight, and body mass index (BMI) were 31 kg, 130 cm, and 18.3 kg/m 2 , respectively, at the time of admission. His blood investigation, inflammatory markers, and hyper coagulable work-up at the time of admission revealed elevated inflammatory markers but did not show any preexisting prothrombotic state (Table 1 ). Gangrenous remnant jejunum was resected, stump was closed using GIA staplers (Medtronic Covidien DST series GIA 6038s blue color) and tube gastrostomy was performed for biliary drainage. The resected specimen showed ischemic necrosis of all the layers of intestine along with areas of hemorrhage and fibrin. It revealed acute perivisceral inflammation; the mesenteric vessel showed complete thrombus with dense inflammatory infiltrates in the endothelium. The tissue subjected for COVID-19 RT-PCR (reverse transcriptase polymerase chain reaction) revealed the presence of significant copies of viral RNA. He was managed by total parenteral nutrition and anticoagulation (low molecular weight heparin) for 3 months, The Fr size tube drain. Recipient received four doses of antithymocyte globulin (ATG)/ day at 1.5 g/kg body weight starting as induction therapy given intraoperatively. CD3 lymphocyte counts were monitored to achieve a target range of <10 cells/μl. Methyl prednisone 500 mg was given before implantation of the graft. Tacrolimus was administered enterally from the first postoperative day and the dose titrated to maintain a trough level of 10-15 ng/ml. The methyl prednisone was tapered to 10 mg about 2 weeks after the transplant and tab mycophenolate was introduced on day 10 when the oral feeds were initiated. reported in up to 16% of patients. 5 As per recent meta-analysis of 29 studies predominant gastrointestinal symptoms were anorexia candidates should be delayed for at least 14-21 days after symptom resolution and two negative SARS-CoV-2 diagnostic tests before the transplant for optimal outcomes. 17 The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation. Data sharing is not applicable to this article, as no data sets were generated or analyzed during the current study. https://orcid.org/0000-0002-3304-5876 Hunaid Hatimi https://orcid.org/0000-0003-4355-5471 Coronavirus disease 2019: a new severe acute respiratory syndrome from Wuhan in China Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a hong kong cohort: systematic review and meta-analysis Superior mesenteric artery thrombosis and acute intestinal ischemia as a consequence of COVID-19 infection Arterial mesenteric thrombosis as a complication of SARS-CoV-2 infection Our early experience with mesenteric ischemia in COVID-19 positive patients Living related small bowel transplantation: donor surgical technique Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis Superior mesenteric arterial and venous thrombosis in COVID-19 Hematological findings and complications of COVID-19 Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation The current state of intestinal transplantation Current indications for and prospects of living related intestinal transplantation Annual Data Report: Intestine Clinical best practice advice for hepatology and liver transplant providers during the covid-19 pandemic: Aasld expert panel consensus Statement Standard Operating Procedure for doing transplants during the COVID 19 Pandemic Successful liver transplantation in a patient recovered from COVID-19 Liver transplant in a recently COVID-19 positive child with hepatoblastoma. Pediatr Transplant. 2020;e13880 Pediatric living donor intestine transplant following an atypical complication of COVID-19: A unique case report from India